Damien Mcdevitt
Found 2 people in New York, California, Pennsylvania and other states
-
+99
-
+98
-
+97
-
-
+95
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Damien Mcdevitt, Ph.D. - @McdevittDamien
🇮🇪CEO @aspenneuro. Delivering transformational cell therapy medicines to Parkinsons patients. #YNWA ⚽. Opinions are my own.
Damien mcdevitt - @mcdevitt_damien
Biotech Exec
Sponsored by SpokeoPaid Service
Sponsored by PeopleLookerPaid Service
Sponsored by SpokeoPaid Service
Damien Mcdevitt
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Damien Mcdevitt - @darknw
2 followers
damienmcdevitt - @damienmcdevitt
2 followers
Daniel - @danielmcdevitt765
Daniel
Instagram-daniel_mcdevitt12
Baseball
Snap-danielmcdev2021
FL
1,952 followers
dmcdevitt - @dmcdevitt
178 followers
Damien McDevitt - @damienmcdevitt2906
20 subscribers
Damien McDevitt - @socialbutterflies
17 subscribers
Damien McDevitt - @damienmcdevitt4707
My name:kieran like:things with engines dont like:books I have a wii u,x box,psp,playstation.
1 subscriber
Damien McDevitt
Aspen Neuroscience
Damien McDevitt
Intern at Turner Construction & studying EE at ...
Matt Killeen, Ph.D.
Vista Point Bio
Education: University of Cambridge ...
Samuel Murphy
Salubris Biotherapeutics
Mark Spyvee
RexChem Research
Education: University of Oxford ...
Tom Dubensky
ImmuneSensor Therapeutics
Education: University ...
Ying Huang
Sharon Benzeno, PhD
Chief Commercial Officer, Immune Medicine
Damien Mcdevitt
Sponsored by PeopleLookerPaid Service
Search for Damien Mcdevitt's city and state history
Search address historyAspen Neuroscience Announces Appointment of Damien McDevitt, PhD as President and Chief Executive Officer
PR Newswire - Mon, 25 Jan 2021
3 Akcea execs, including CEO, leave in a ‘disconcerting surprise’
BioPharma Dive - Mon, 23 Sep 2019
Damien McDevitt moves from GSK to Acadia Pharmaceuticals
PMLiVE - Thu, 21 Dec 2017
Trial testing Parkinson’s cell therapy ANPD001 treats 1st patient
Parkinson's News Today - Wed, 24 Apr 2024
Aspen Neuroscience Appoints Ana Sousa Chief Regulatory Officer
PR Newswire - Tue, 16 Jan 2024
Fr McDevitt's 50 years of service honoured
The Irish Independent - Fri, 03 Jan 2020
Stephen O'Neill pulls strings as Tyrone beat Kerry in feisty Masters final
Irish Examiner - Sat, 16 Sep 2023
Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners
PR Newswire - Mon, 09 May 2022
Best and brightest at Deele College celebrated at annual Prizegiving
Donegal Daily - Sun, 26 May 2024
Champions Tyrone prepare to face Dublin in semis Photo 1 of 1 Alpha Newspaper Group
strabaneweekly.co.uk - Sat, 26 Aug 2023
Damien Mcdevitt - @damienmcdevitt
0 photos - 0 followers
Damien McDevitt - @lordbobbill
0 followers
Damien McDevitt - @896998mcd
0 followers
Damien McDevitt - @damienmcdevitt
0 followers
Leadership Team - Aspen
damien mcdevitt, phd President and Chief Executive Officer A distinguished leader in the biotech and pharmaceutical industry sectors, Damien is recognized for his vision, strategic planning, and corporate leadership.
Aspen Neuroscience announces appointment of Damien …
SAN DIEGO, January 25, 2021 — Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson’s disease, …
Aspen Neuroscience Announces Appointment of …
SAN DIEGO, Jan. 25, 2021 /PRNewswire/ -- Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson's disease, announced today...
Aspen Neuroscience Announces First Patient Dosed …
“The initiation of this clinical trial is a major milestone in Aspen’s mission to develop and deliver personalized, regenerative neurologic therapies for people with unmet medical needs, starting with Parkinson’s disease,” said …
Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from …
ANPD001 was developed in California, and is now being produced and studied here," said Damien McDevitt, PhD, President and CEO of Aspen Neuroscience, Inc. "Providing patients in …
Aspen Neuroscience Announces Appointment of Damien …
Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson's disease, announced today that it …
Damien Mcdevitt - President and CEO at Aspen …
A distinguished leader in the biotech and pharmaceutical industry sectors, Damien is recognized for his vision, strategic planning, and corporate leadership.
Damien McDevitt, Aspen Neuroscience Inc: Profile and Biography ...
Damien McDevitt is President/CEO at Aspen Neuroscience Inc. See Damien McDevitt's compensation, career history, education, & memberships.
CEO, Damien McDevitt, Named in San Diego Business Journal's …
Our CEO, Damien McDevitt, was named in the San Diego Business Journal’s 500 Most Influential People in San Diego. With over two decades of experience in life sciences, Damien is leading …
FDA clears Phase 1/2a trial of stem cell therapy for Parkinson's...
FDA clearance “sets in motion a path toward a new treatment for the more than one million Americans and 10 million people worldwide with Parkinson’s disease,” Damien …
Aspen Neuroscience Pursues Autologous Cell Therapies for …
“We would hope to get the IND filed in the beginning of 2023, and then be able to start dosing our patients in 2023 as well,” Aspen President and CEO Damien McDevitt, PhD, …
Aspen Neuroscience Announces FDA Clearance of …
"The IND clearance of ANPD001 sets in motion a path toward a new treatment for the more than one million Americans and 10 million people worldwide with Parkinson's …
CEO Damien McDevitt, PhD, Featured in Biocom's Article, “A …
Aspen Neuroscience’s CEO, Damien McDevitt, PhD, was featured in Biocom California’s article, “A Look at the Year Ahead for Life Sciences.” Damien states, “The lack of treatment options …
ACADIA Pharmaceuticals Announces Appointment of Damien …
ACADIA Pharmaceuticals Inc. announced that Damien McDevitt, Ph.D., has joined ACADIA as Senior Vice President Corporate Development.
FDA Fast Tracks Parkinson’s Treatment Application
“We are pleased that the FDA has granted Fast Track Designation, underscoring the potential of an autologous dopamine replacement therapy such as ANPD001 to serve as a …
Series B Financing Announced - Aspen
“As the leader in autologous cell therapy development, Aspen Neuroscience is preparing to study its first cell replacement candidate in Parkinson’s disease,” said Damien McDevitt, Ph.D., …